During the past decade, Klinikum Passau conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Passau" #1 sponsor was "University of Ulm" with 7 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "Christian Buske" with 1 trials sponsored, "Dominik Paul Modest" with 1 trials sponsored and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Passau" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "AMC Wolfartklinik Gräfelfing" with 1 trials as a collaborator, "AOK Bayern" with 1 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Deutsche Stiftung für chronisch Kranke" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Passau" are "Acute Myeloid Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials), "Atrial Fibrillation" (1 trials) and "Carotid Artery Stenosis" (1 trials). Many other conditions were trialed in "Klinikum Passau" in a lesser frequency.

Most popular intervention types in "Klinikum Passau" are "Drug" (13 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (5 trials), "Daunorubicin" (3 trials), "Dasatinib" (2 trials), "Idarubicin" (2 trials) and "Midostaurin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Passau" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Passau". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum Passau, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Passau, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".